Stimulation of the Larynx to Treat Unexplained Chronic Cough
ConditionCough
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-88
SponsorUniversity of Minnesota
About this trial
Researchers will test the effect of non-invasive vibrotactile stimulation of the larynx on symptom severity of unexplained chronic cough.
Eligibility criteria
Qualifiers
Adults aged 18-88
>8 weeks of cough
Cough visual analogue scale (VAS): Rating of 30 or greater on a 0-100 cough severity scale
Ability to provide informed consent and independently complete questionnaires
Disqualifiers
Electronic implants (e.g., pacemaker)
Currently doing speech therapy for cough
Contraindications to safe or effective VTS device use
No regular access to wifi internet Neuromuscular impairment that may affect cough/laryngeal sensation and/or function (e.g., multiple system atrophy, Parkinson, CVA, vocal fold paralysis or paresis)
Trial design
Treatments tested in this trial
- Vibrotactile Stimulation
Treatment groups
60 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov